These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 9339961

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A, Terra C, Guevara M, Ginès P.
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract] [Full Text] [Related]

  • 25. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Feb; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, Planas R, Bosch J, Arroyo V, Rodés J.
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [Abstract] [Full Text] [Related]

  • 30. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
    Knotek M, Rogachev B, Schrier RW.
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():112D-121D. PubMed ID: 11110623
    [Abstract] [Full Text] [Related]

  • 31. Progress in treatment of massive ascites and hepatorenal syndrome.
    Gerbes AL, Gulberg V.
    World J Gastroenterol; 2006 Jan 28; 12(4):516-9. PubMed ID: 16489662
    [Abstract] [Full Text] [Related]

  • 32. Hepatorenal syndrome and ascites--questions and answers.
    Bernardi M, Blendis L, Burroughs AK, Laffi G, Rodes J, Gentilini P.
    Liver; 1999 Jan 28; 19(1 Suppl):15-74. PubMed ID: 10227000
    [No Abstract] [Full Text] [Related]

  • 33. Management of ascites in children.
    Lane ER, Hsu EK, Murray KF.
    Expert Rev Gastroenterol Hepatol; 2015 Jan 28; 9(10):1281-92. PubMed ID: 26325252
    [Abstract] [Full Text] [Related]

  • 34. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
    Pose E, Cardenas A.
    Dig Dis; 2017 Jan 28; 35(4):402-410. PubMed ID: 28468013
    [Abstract] [Full Text] [Related]

  • 35. The pathophysiologic basis for the treatment of cirrhotic ascites.
    Wong F, Blendis L.
    Clin Liver Dis; 2001 Aug 28; 5(3):819-32. PubMed ID: 11565142
    [Abstract] [Full Text] [Related]

  • 36. Ascites.
    Gordon FD.
    Clin Liver Dis; 2012 May 28; 16(2):285-99. PubMed ID: 22541699
    [Abstract] [Full Text] [Related]

  • 37. Hepatorenal syndrome and ascites--an introduction.
    Gentilini P.
    Liver; 1999 May 28; 19(1 Suppl):5-14. PubMed ID: 10226999
    [No Abstract] [Full Text] [Related]

  • 38. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ, de Man RA, van Buuren HR.
    Aliment Pharmacol Ther; 2007 Dec 28; 26 Suppl 2():183-93. PubMed ID: 18081661
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hepatorenal syndrome.
    Biswas KD, Jain AK.
    Trop Gastroenterol; 2002 Dec 28; 23(3):113-6. PubMed ID: 12693150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.